| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.22 | 1e-08 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.22 | 7e-08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.3 | 5e-07 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-05 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-05 |